Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway
|更新时间:2026-01-05
|
Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway
“The latest research has found that the combination of Shenmai injection and cisplatin in the treatment of non-small cell lung cancer activates the endoplasmic reticulum stress signaling pathway, induces tumor cell apoptosis, and has a synergistic effect on tumor inhibition.”
Chinese Journal of Experimental Traditional Medical FormulaePages: 1-9(2026)
GUO Shengnan, CAO Hao, WANG Dan, et al. Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway[J/OL]. Chinese Journal of Experimental Traditional Medical Formulae, 2026, 1-9.
DOI:
GUO Shengnan, CAO Hao, WANG Dan, et al. Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway[J/OL]. Chinese Journal of Experimental Traditional Medical Formulae, 2026, 1-9. DOI: 10.13422/j.cnki.syfjx.20250825.
Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway